“NGL had a record sales year in our Preneed line of business while still growing income and surplus. We are grateful for the hard work of our sales representatives, marketing partners and employees who helped make that happen,” said Nancy Stoddard, NGL Senior Vice President, Chief Financial Officer & Chief Actuary.

NGL and its subsidiaries reported a record sales year of $790 million in 2017, which is an increase of 8% over 2016. The 2017 sales results contributed to the growth of the consolidated statutory assets to $4.3 billion.